Cai Jingsheng, Yang Fan, Wang Xun
Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
J Clin Med. 2022 Mar 3;11(5):1399. doi: 10.3390/jcm11051399.
The number of researches on occult non-small cell lung cancer (NSCLC) is modest. Herein, we defined the clinicopathological features, prognosis and survival outcome of this underappreciated tumor, with purpose of obtaining a clearer picture on this disease.
The entire cohort was categorized into two groups (occult NSCLC and other NSCLC) and further into five groups (occult, T1, T2, T3 and T4). A least absolute shrinkage and selection operator (LASSO) penalized Cox regression model was performed to identify the prognostic indicators. A nomogram and a risk-classifying system were formulated. Kaplan-Meier with Log-rank method was carried out to compare overall survival (OS) and cancer specific survival (CSS) differences between groups.
59,046 eligible NSCLC cases (occult NSCLC: 1158 cases; other NSCLC: 57,888 cases) were included. Occult NSCLC accounted for 2.0% of the included cases. Multivariate analysis revealed that age, sex, tumor location, histology, grade and surgery were prognostic factors for OS. The corresponding prognostic nomogram classified occult NSCLC patients into low-risk and high-risk group, and its performance was acceptable. Survival curves demonstrated that occult NSCLC patients exhibited worse survivals than other NSCLC. In further analyses, the survival of low-risk occult NSCLC and stage T3 NSCLC were comparable, and the high-risk occult NSCLC patients still owned the worst survival rate.
Occult NSCLC was an aggressive tumor with poor prognosis, and surgery was the preferred treatment. More attention should be paid to this overlooked disease due to no evidence of tumor imaging.
关于隐匿性非小细胞肺癌(NSCLC)的研究数量有限。在此,我们定义了这种未得到充分重视的肿瘤的临床病理特征、预后和生存结果,旨在更清楚地了解这种疾病。
将整个队列分为两组(隐匿性NSCLC和其他NSCLC),并进一步分为五组(隐匿性、T1、T2、T3和T4)。采用最小绝对收缩和选择算子(LASSO)惩罚Cox回归模型来识别预后指标。制定了列线图和风险分类系统。采用Kaplan-Meier法和Log-rank检验比较各组之间的总生存(OS)和癌症特异性生存(CSS)差异。
纳入了59046例符合条件的NSCLC病例(隐匿性NSCLC:1158例;其他NSCLC:57888例)。隐匿性NSCLC占纳入病例的2.0%。多因素分析显示,年龄、性别、肿瘤位置、组织学类型、分级和手术是OS的预后因素。相应的预后列线图将隐匿性NSCLC患者分为低风险和高风险组,其性能良好。生存曲线表明,隐匿性NSCLC患者的生存率低于其他NSCLC患者。在进一步分析中,低风险隐匿性NSCLC和T3期NSCLC的生存率相当,而高风险隐匿性NSCLC患者的生存率仍然最差。
隐匿性NSCLC是一种侵袭性肿瘤,预后较差,手术是首选治疗方法。由于没有肿瘤影像学证据,这种被忽视的疾病应得到更多关注。